This inventor holds 1 USPTO granted patent. Top assignee: Shanghai Abelzeta Ltd.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Jiyan Hou: Innovator in Tumor-Infiltrating Lymphocyte Expansion
Introduction
Jiyan Hou is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of cancer research, particularly in the area of tumor-infiltrating lymphocytes (TILs). His innovative methods have the potential to enhance cancer treatment by improving the availability of TILs for therapeutic use.
Latest Patents
Jiyan Hou holds a patent for "Methods for preparing tumor-infiltrating lymphocytes." This patent outlines methods for expanding TILs, which include co-culturing an initial cell population containing TILs with first feeder cells to obtain a first expanded cell population. Subsequently, the first expanded cell population is co-cultured with second feeder cells to obtain an expanded TIL population. These methods can quickly produce a large number of TILs from a small tumor sample, which is crucial for effective cancer therapies.
Career Highlights
Jiyan Hou is associated with Shanghai Abelzeta Ltd., where he continues to work on advancing cancer treatment methodologies. His research and innovations have positioned him as a key figure in the field of immunotherapy.
Collaborations
Jiyan collaborates with talented individuals such as Jia Li and Zizhen Gong, who contribute to his research efforts and help in the development of innovative solutions in cancer treatment.
Conclusion
Jiyan Hou's work in expanding tumor-infiltrating lymphocytes represents a significant advancement in cancer research. His innovative methods and collaborations are paving the way for more effective cancer therapies.